Cargando…
Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against Mycobacterium kansasii
The incidence of infections with nontuberculous mycobacteria (NTM) has been increasing worldwide. The emergence of multidrug-resistant NTM is a serious clinical concern, and a vaccine for NTM has not yet been developed. We previously developed a new recombinant Bacillus Calmette–Guérin (rBCG) vaccin...
Autores principales: | Komine-Aizawa, Shihoko, Mizuno, Satoru, Matsuo, Kazuhiro, Namiki, Takahiro, Hayakawa, Satoshi, Honda, Mitsuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8618695/ https://www.ncbi.nlm.nih.gov/pubmed/34835191 http://dx.doi.org/10.3390/vaccines9111260 |
Ejemplares similares
-
The Induction of Antigen 85B-Specific CD8(+) T Cells by Recombinant BCG Protects against Mycobacterial Infection in Mice
por: Komine-Aizawa, Shihoko, et al.
Publicado: (2023) -
Recombinant AhpC antigen from Mycobacterium bovis boosts BCG-primed immunity in mice
por: DÜZENLİ, Özgün Fırat, et al.
Publicado: (2021) -
Adverse events after BNT162b2 mRNA COVID-19 vaccination in health care workers and medical students in Japan
por: Namiki, Takahiro, et al.
Publicado: (2022) -
Protection against highly pathogenic SIV by BCG-SIV recombinant priming and attenuated replicating vaccinia-SIV recombinant boosting
por: Zhang, X, et al.
Publicado: (2012) -
Placental barrier against COVID-19
por: Komine-Aizawa, Shihoko, et al.
Publicado: (2020)